742Dash

The problem is that a healthy person's "personal choice" puts those who can not get vaccinated (infants and transplant patients, for example) at risk. It really is not about "you" or "me", it is about the herd that we call our fellow citizens. And the herd needs an 80% to 90% vaccination rate to stay healthy.

c250ft

Yes, I undrstand 100% the logic behind the vaccination movement as I am very educated on the matter. I stand behind my statement of it being a personal choice. I won't try and convince you, nor expect you to convince me of your reasoning. We each have our own thinking and reasoning behind our mindset.

JamesNoBrakes

And if you could move to an island where you would stay forever without interacting with anyone else, that would make sense...

CaptYoda

I had the yellow fever vaccine a couple of times (they are good for 10 yrs). Also had Thyphoid, Cholera, Hepatitis, Tetanus. In my case, no issues with them other than some discomfort and side-effect 24-48 hrs later. I was in Africa and South Asia, and so for me it was not something to debate.

Twin Wasp

Well American doesn't fly to any area where a YF vaccination is required. You are about equally likely to die from YF as from the vaccine as a tourist in South America. Go to Africa and you are 10 times more likely to die from YF as from the vaccine. Neither sets of numbers counts people who get sick but don't die. However YF has an eighty percent fatality rate for non vaccinated US tourists over the last 40 years.

c250ft

Maybe we'll get to fly together, and be stuck in the same cockpit for hours together...and you'll never know

Carl Spackler

You can opt out of the vaccine for various reasons. If you do, you won't be able to ever fly to any of the yellow fever destinations. The vaccine is nasty for some people and dangerous for some. This is from the CDC:


Vaccine Safety and Adverse Reactions

Common adverse reactions

Reactions to yellow fever vaccine are generally mild; 10%–30% of vaccinees report mild systemic adverse events. Reported events typically include low-grade fever, headache, and myalgias that begin within days after vaccination and last 5–10 days. Approximately 1% of vaccinees temporarily curtail their regular activities because of these reactions.

Severe adverse reactions

Hypersensitivity

Immediate hypersensitivity reactions, characterized by rash, urticaria, or bronchospasm are uncommon. Anaphylaxis after yellow fever vaccine is reported to occur at a rate of 1.8 cases per 100,000 doses administered.

Yellow fever vaccine–associated neurologic disease (YEL-AND)

YEL-AND represents a conglomerate of clinical syndromes, including meningoencephalitis, Guillain-Barré syndrome, acute disseminated encephalomyelitis, and rarely, cranial nerve palsies. Historically, YEL-AND was seen primarily among infants as encephalitis, but more recent reports have been among people of all ages.

The onset of illness for documented cases is 3–28 days after vaccination, and almost all cases were in first-time vaccine recipients. YEL-AND is rarely fatal. The incidence of YEL-AND in the United States is 0.8 per 100,000 doses administered. The rate is higher in people aged ≥60 years, with a rate of 1.6 per 100,000 doses in people aged 60–69 years and 2.3 per 100,000 doses in people aged ≥70 years.

Yellow fever vaccine–associated viscerotropic disease (YEL-AVD)

YEL-AVD is a severe illness similar to wild-type disease, with vaccine virus proliferating in multiple organs and often leading to multiple organ dysfunction syndrome or multiorgan failure and death. Since the initial cases of YEL-AVD were published in 2001, >65 confirmed and suspected cases have been reported throughout the world.

YEL-AVD has been reported to occur only after the first dose of yellow fever vaccine; there have been no reports of YEL-AVD following booster doses. The median time from yellow fever vaccination until symptom onset for YEL-AVD cases was 4 days (range, 0–8 days). The case-fatality ratio for all reported YEL-AVD cases worldwide is approximately 60%. The incidence of YEL-AVD in the United States is 0.4 cases per 100,000 doses of vaccine administered. The rate is higher for people aged ≥60 years, with a rate of 1.0 per 100,000 doses in people aged 60–69 years and 2.3 per 100,000 doses in people aged ≥70 years.

BPWI

Have had it twice without any issues. Sounds like a wives tale. As was said earlier, if you arent interested in the vaccine simply dont bid for all the lovely locals that require it.

Justdoinmyjob

As long as he's had is vaccinations, it wouldn't matter.

iceman49

So the CDC puts out wives tales and myths.